OpenLegislation

The Medicines for Human Use (Prohibition) (Senecio and Miscellaneous Amendments) Order 2008

S.I. 2008/548 · Made 28 February 2008 · Extends to United Kingdom

Up to date with all changes known to legislation.gov.uk, revised to 31 December 2020.

MEDICINES

Made 28th February 2008

Laid before Parliament 6th March 2008

Coming into force 1st April 2008

The Secretary of State for Health and the Minister for Health, Social Services and Public Safety, acting jointly, make the following Order in the exercise of powers conferred upon them by sections 62(1)(a) and (2) and 129(4) of the Medicines Act 1968 M1 or, in the case of the Minister, the powers conferred by those provisions and now vested in him M2. It appears to them to be necessary to make the Order in the interests of safety.

In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be substantially affected by this Order. In accordance with sections 62(3) and 129(7) of that Act they have consulted and taken into account the advice of the Herbal Medicines Advisory Committee M3. They have also taken into account the report of the Committee made under section 62(5) of that Act.

Annotations to the whole text

Marginal citations

M1

1968 c.67. The expression “the Ministers”, which is relevant to the powers being exercised in the making of this Order, is defined in section 1 of the Act, as amended by article 2(2) of, and Schedule 1 to, S.I. 1969/388, by article 2(1) of, and the Schedule to, S.I. 1999/3142, and by paragraph 2 of Part 1 of Schedule 8 to S.I. 2006/2407. Section 62 was amended by S.I. 2005/1094 and paragraph 35 of Part 1 of Schedule 8 to S.I. 2006/2407.

M2

By virtue of the powers vested in the Ministers in charge of that Department by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c.47) may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c.1); the Department was renamed by virtue of article 3(6) of S.I. 1999/283 (N.I.1).

M3

See section 4(6) of the Medicines Act 1968, as substituted by regulation 5(5) of S.I. 2005/1094, for the definition of “appropriate committee” in section 62(3) and (5).

Contents

  1. 1Citation, commencement and interpretation
  2. 2Prohibition of sale, supply and importation of any medicinal product consisting of or containing Senecio
  3. 3Exceptions to the prohibition imposed by article 2
  4. 4Amendment of the Medicines (Bal Jivan Chamcho Prohibition) (No.2) Order 1977
  5. 5Amendment of the Medicines (Aristolochia and Mu Tong etc) (Prohibition) Order 2001
  6. 6Amendment of the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002
  7. Signature
  8. Explanatory note

1Citation, commencement and interpretation

(1)

This Order may be cited as the Medicines for Human Use (Prohibition) (Senecio and Miscellaneous Amendments) Order 2008 and shall come into force on 1st April 2008.

(2)

In article 3 —

  • “F1approved country for import” has the meaning given in regulation 8(1) of the Human Medicines Regulations 2012;

  • “the Act” means the Medicines Act 1968;

  • “external use” means application to the skin, hair, teeth, mucosa of the mouth, throat, nose, ear, eye, vagina or anal canal when a local action only is intended and extensive systemic absorption is unlikely to occur;

  • F2...

  • ...

2Prohibition of sale, supply and importation of any medicinal product consisting of or containing Senecio

Except as provided for in article 3, the sale, supply or importation of any medicinal product consisting of or containing—

(a)

a plant M1 belonging to the species Senecio; or

(b)

an extract from such a plant,

is prohibited.

3Exceptions to the prohibition imposed by article 2

The prohibition imposed by article 2 shall not apply where the medicinal product is—

(a)
(i)

for external use only; and

(ii)

not a teething preparation, throat spray, throat pastille, throat lozenge, throat tablet, nasal spray or nasal inhalation or nasal drops;

(b)

sold or supplied to, or imported by or on behalf of, any of the following persons—

(i)

an authorised officer within the meaning of section 5(6) of the Food Safety Act 1990 M1 or Article 2(2) of the Food Safety (Northern Ireland) Order 1991 M2,

(ii)

a food analyst or food examiner within the meaning of section 30 of the Food Safety Act 1990 M3 or Article 30 or 31 of the Food Safety (Northern Ireland) Order 1991 M4,

(iii)

a person duly authorised by an enforcement authority under sections 111 M5 and 112 of the Act, or

(iv)

a sampling officer within the meaning of paragraph 1(1) of Schedule 3 to the Act M6;

F1(c)

is imported from an approved country for import, and is being, or is to be, exported to a country other than the United Kingdom; or

(d)

the subject F2of a F3UK marketing authorisation, certificate of registration or traditional herbal registration within the meaning of the Human Medicines Regulations 2012.

4Amendment of the Medicines (Bal Jivan Chamcho Prohibition) (No.2) Order 1977

(1)

The Medicines (Bal Jivan Chamcho Prohibition) (No.2) Order 1977 M1 is amended as follows.

(2)

In article 2—

(a)

for paragraph (4) substitute —

“(4)

The prohibition imposed by paragraph (1) above shall not apply where the medicinal product is imported from an EEA State, if the product—

(a)

originates in an EEA State, or

(b)

originates outside the European Economic Area, but is in free circulation in member States,

and is being, or is to be, exported to a third country or an EEA State other than the United Kingdom.”; and

(b)

after paragraph (4), insert —

“(5)

For the purposes of paragraph (4)—

  • “free circulation in member States” has the same meaning as in Article 23.2, as read with Article 24, of the Treaty establishing the European Community;

  • “third country” means any country other than an EEA State.”.

5Amendment of the Medicines (Aristolochia and Mu Tong etc) (Prohibition) Order 2001

(1)

The Medicines (Aristolochia and Mu Tong etc) (Prohibition) Order 2001 M1 is amended as follows.

(2)

In article 1 (citation, commencement and interpretation), in paragraph (2)—

(a)

after the definition of “the Act”, insert —

““free circulation in member States” has the same meaning as in Article 23.2, as read with Article 24, of the Treaty establishing the European Community;”;

(b)

omit the definitions of “EEA Agreement” and “EEA State”;

(c)

after the definition of “medicinal product”, insert —

“third country” means any country other than an EEA State.”.

(3)

In article 4, for paragraph (3), substitute —

“(3)

The prohibition imposed by articles 2 and 3 above shall not apply where the medicinal product is imported from an EEA State, if the product—

(a)

originates in an EEA State, or

(b)

originates outside the European Economic Area, but is in free circulation in member States,

and is being, or is to be, exported to a third country or an EEA State other than the United Kingdom.”.

6Amendment of the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002

(1)

The Medicines for Human Use (Kava-kava) (Prohibition) Order 2002 M1 is amended as follows.

(2)

In article 1(2)—

(a)

omit the definitions of “EEA Agreement” and “EEA State”;

(b)

after the definition of “medicinal product”, insert —

“third country” means any country other than an EEA State.”.

(3)

In article 3, for paragraph (c), substitute the following—

“(c)

imported from an EEA State, if the product—

(i)

originates in an EEA State, or

(ii)

originates outside the European Economic Area, but is in free circulation in member States,

and is being, or is to be, exported to a third country or an EEA State other than the United Kingdom.”.

Signature

Signed by authority of the Secretary of State for Health.

Dawn Primarolo

Minister of State,

Department of Health

Michael McGimpsey

Minister for Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Order)

This Order prohibits the sale, supply or importation of any medicinal product for human use which consists of or contains a plant, or part of a plant, belonging to the species Senecio or an extract from such a plant.

This prohibition is subject to exceptions.

This Order also makes minor amendments to three existing Orders made under section 62 of the Medicines Act 1968: the Medicines (Bal Jivan Chamcho Prohibition) (No.2) Order 1997 (S.I.1977/670); the Medicines (Aristolochia and Mu Tong etc) (Prohibition) Order 2001 (S.I.2001/1841); and the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002 (S.I.2002/3170). The amendments ensure that the exception for goods in transit in the three Orders applies to goods imported from an EEA State which are to be exported to a third country or an EEA State other than the United Kingdom.

This Order was notified to the European Commission in accordance with Article 8 of the European Parliament and Council Directive 98/34/EC (OJ No. L204, 21.7.1998, p.37), as amended by Article 1(4) of the European Parliament and Council Directive 98/48/EC (OJ No. L217, 5.8.1998, p.18).

A full regulatory impact assessment of the effect that this instrument will have on the costs of business is available from the Medicines and Healthcare products Regulatory Agency, Information Centre, Room 10-202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ. Copies have been placed in the libraries of both Houses of Parliament.